p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors

p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4161/CC.11.3.19076
P698PubMed publication ID22262171

P50authorNina-Naomi KreisQ90877752
P2093author name stringThorsten Berg
Frank Louwen
Brigitte Zimmer
Juping Yuan
Mourad Sanhaji
P433issue3
P304page(s)543-553
P577publication date2012-02-01
P1433published inCell CycleQ1254166
P1476titlep53 is not directly relevant to the response of Polo-like kinase 1 inhibitors
P478volume11

Reverse relations

cites work (P2860)
Q36839342B-cell lymphoma 6 promotes proliferation and survival of trophoblastic cells
Q38129174Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy
Q36544129Characterization of adipose-derived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells
Q51411634Deficiency of RITA results in multiple mitotic defects by affecting microtubule dynamics.
Q26991736Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
Q34998646Function of survivin in trophoblastic cells of the placenta
Q38856254Functional analysis of phosphorylation of the mitotic centromere-associated kinesin by Aurora B kinase in human tumor cells
Q37708943Impact of Polo-like kinase 1 inhibitors on human adipose tissue-derived mesenchymal stem cells
Q64073233In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53
Q35740037Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition
Q64078481Non-canonical cMet regulation by vimentin mediates Plk1 inhibitor-induced apoptosis
Q52352270PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells.
Q91689936Polo-Like Kinase 1 phosphorylates and stabilizes KLF4 to promote tumorigenesis in nasopharyngeal carcinoma
Q41866750Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53.
Q38984499Polo-like kinase 1 regulates the stability of the mitotic centromere-associated kinesin in mitosis
Q38199282Polo-like kinase-1 in DNA damage response
Q91643126Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status
Q41694208The activity regulation of the mitotic centromere-associated kinesin by Polo-like kinase 1
Q47135845The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation

Search more.